Cargando…
Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis as a Possible Side Effect of COVID-19 Vaccination
Vaccination is the principal tool aimed at curbing the COVID-19 pandemic that has, so far, affected tens of millions of individuals in the United States. The two available mRNA vaccines developed by Pfizer-BioNTech and Moderna possess high efficacy in preventing infection and illness severity. Howev...
Autores principales: | Noel, Edva, Rashid, Urmiya, Rabbani, Rizwan, Khan, Waqas Ahmad, Benjamin, Yves-Smith, Lee, Iris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674930/ https://www.ncbi.nlm.nih.gov/pubmed/36415412 http://dx.doi.org/10.7759/cureus.30565 |
Ejemplares similares
-
Antineutrophil Cytoplasmic Autoantibody–Associated Glomerulonephritis Following the Pfizer-BioNTech COVID-19 Vaccine
por: Dube, Geoffrey K., et al.
Publicado: (2021) -
SARS-CoV-2 Vaccination as a Trigger for Perinuclear Antineutrophil Cytoplasmic Antibodies (p-ANCA) Associated With Rapidly Progressive Glomerulonephritis
por: Cano-Gámez, Tábata, et al.
Publicado: (2022) -
Antineutrophil Cytoplasmic Antibody and Multiple Sclerosis
por: George, Jason C., et al.
Publicado: (2017) -
Treatment of Aggressive Antineutrophil Cytoplasmic Antibody–Associated Vasculitis With Eculizumab
por: Huizenga, Noah, et al.
Publicado: (2019) -
Antineutrophil cytoplasm antibody positivity, kidney impairment, and cholesterol embolization
por: Farrah, Tariq E., et al.
Publicado: (2021)